Capillary electrophoresis-mass spectrometry for targeted and untargeted analysis of the sub-5 kDa urine metabolome of patients with prostate or bladder cancer: a feasibility study
[en] Targeted and untargeted analyses of the sub-5 kDa urine metabolome of genitourinary cancer patients (prostate and/or bladder) were performed without chemical derivatization using capillary electrophoresis-electrospray ionization-mass spectrometry (CE-ESI-MS). For targeted analysis, endogenous levels of sarcosine and 5 other amino acid metabolites implicated in the progression of prostate cancer were quantified in four patients and in a pooled urine sample from healthy volunteers. An untargeted analysis (m/z 50 to 850) of patient urine was performed using the same CE-ESI-MS system identifying over 400 distinct molecular features per patient. All patient urine samples were collected at prostatectomy/cystectomy via catheter. Patient urine samples were filtered by centrifugation, with endogenous sarcosine enriched by solid-phase extraction, and the processed samples loaded onto CE-ESI-MS for analysis. Diagnostic information, digital pathological slides, and tissue samples were collected and stored in a comprehensive biobanking database. The introduction of urine sample collection into the surgery workflow was facile and is a promising strategy for addressing the translational research challenge of moving smoothly from “chromatogram to nomogram”.
Research center :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
MacLennan, Matthew; University of British Columbia - UBC > Department of Chemistry
Kok, Miranda ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Soliman, Laiel; University of British Columbia - UBC > Department of Chemistry
So, Alan; Vancouver Prostate Centre
Hurtado-Coll, Antonio; Vancouver Prostate Centre
Chen, David; University of British Columbia - UBC > Department of Chemistry
Language :
English
Title :
Capillary electrophoresis-mass spectrometry for targeted and untargeted analysis of the sub-5 kDa urine metabolome of patients with prostate or bladder cancer: a feasibility study
Publication date :
01 February 2018
Journal title :
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Rao, A.R., Motiwala, H.G., Karim, O.M. a, The discovery of prostate-specific antigen. BJU Int. 101 (2008), 5–10, 10.1111/j.1464-410X.2007.07138.x.
Wallner, L.P., Jacobsen, S.J., Prostate-specific antigen and prostate cancer mortality: a systematic review. Am. J. Prev. Med. 45 (2013), 318–326, 10.1016/j.amepre.2013.04.015.
Kattan, M.W., Eastham, J.A., Stapleton, A.M.F., Wheeler, T.M., Scardino, P.T., A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 90 (1998), 766–771.
Sreekumar, A., Poisson, L.M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R.J., Li, Y., Nyati, M.K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G.S., Ghosh, D., Pennathur, S., Alexander, D.C., Berger, A., Shuster, J.R., Wei, J.T., Varambally, S., Beecher, C., Chinnaiyan, A.M., Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 (2009), 910–914, 10.1038/nature07762.
Khan, A.P., Rajendiran, T.M., Ateeq, B., Asangani, I.A., Athanikar, J.N., Yocum, A.K., Mehra, R., Siddiqui, J., Palapattu, G., Wei, J.T., Michailidis, G., Sreekumar, A., Chinnaiyan, A.M., The role of sarcosine metabolism in prostate cancer progression. Neoplasia 15 (2013), 491–501, 10.1593/neo.13314.
de Vogel, S., Ulvik, A., Meyer, K., Ueland, P.M., Nygård, O., Vollset, S.E., Tell, G.S., Gregory, J.F. III, Tretli, S., Bjørge, T., Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer - a large nested case-control study within the JANUS cohort in Norway. Int. J. Cancer, 2013, 2–26, 10.1002/ijc.28347.
Tripathi, P., Somashekar, B.S., Ponnusamy, M., Gursky, A., Dailey, S., Kunju, P., Lee, C.T., Chinnaiyan, A.M., Rajendiran, T.M., Ramamoorthy, A., HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease. J. Proteome Res. 12 (2013), 3519–3528 https://doi.org/10.1021/pr4004135.
Soliman, L.C., Hui, Y., Hewavitharana, A.K., Chen, D.D.Y., Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis-tandem mass spectrometry. J. Chromatogr. A 1267 (2012), 162–169, 10.1016/j.chroma.2012.07.021.
Saude, E.J., Sykes, B.D., Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics 3 (2007), 19–27, 10.1007/s11306-006-0042-2.
Gurcan, M.N., Boucheron, L., Can, A., Madabhushi, A., Rajpoot, N., Yener, B., Histopathological image analysis: a review. IEEE Rev. Biomed. Eng. 2 (2009), 147–171, 10.1109/RBME.2009.2034865.Histopathological.
Shukla-Dave, A., Hricak, H., Ishill, N., Moskowitz, C.S., Drobnjak, M., Reuter, V.E., Zakian, K.L., Scardino, P.T., Cordon-Cardo, C., Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin. Cancer Res. 15 (2009), 3842–3849, 10.1158/1078-0432.CCR-08-2453.
Kurhanewicz, J., Magnetic resonance imaging biomarkers of prostate cancer. Am. Assoc. Cancer Res. Educ. B 2008 (2008), 523–526 http://educationbook.aacrjournals.org/cgi/content/full/2008/1/523?maxtoshow=&hits=10&RESULTFORMAT=1&author1=kurhanewicz&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&tdate=4/30/2013&resourcetype=HWCIT.
Zakian, K.L., Sircar, K., Hricak, H., Chen, H.-N., Shukla-Dave, A., Eberhardt, S., Muruganandham, M., Ebora, L., Kattan, M.W., Reuter, V.E., Scardino, P.T., Koutcher, J.A., Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 (2005), 804–814 http://www.ncbi.nlm.nih.gov/pubmed/15734935.
Nimesh, S., Mohottalage, S., Vincent, R., Kumarathasan, P., Current status and future perspectives of mass spectrometry imaging. Int. J. Mol. Sci. 14 (2013), 11277–11301, 10.3390/ijms140611277.
Amling, C.L., Diagnosis and management of superficial bladder cancer. Curr. Probl. Cancer 25 (2001), 219–278.
Gleason, D.F., Histologic grading of prostate cancer: a perspective. Hum. Pathol. 23 (1992), 273–279 https://doi.org/10.1016/0046-8177(92)90108-F.
Maxwell, E.J., Zhong, X., Zhang, H., van Zeijl, N., Chen, D.D.Y., Decoupling CE and ESI for a more robust interface with MS. Electrophoresis 31 (2010), 1130–1137, 10.1002/elps.200900517.
Salter, C., Error analysis using the variance-covariance matrix. J. Chem. Educ., 77, 2000, 1239, 10.1021/ed077p1239.
